The combination of reduced expression of cluster of differentiation (CD) 133 and cyclo‐oxygenase (COX) 2 and increased density of CD8+ tumour‐infiltrating lymphocytes is a significant predictor of tumour response to preoperative chemoradiotherapy (CRT). The gene discussed is CD8A; the disease is neoplasm.